• Adam Manhi (chair)

• Liv Bryan (programme manager)

• Trishna Bharadia (patient)

• Hayley Hall (lay)

• Shira Peleg Hasson (clinical)

• Jennifer McCaffery (lay)

• Thomas Smith (patient)

No conflicts declared by panel

Approved

• Lay summary was clear and comprehensive, providing detailed context of the disease and treatment landscape (incl.statistics)

• Use cases were strong and well explained with clear objectives and specificity around how real-life patient benefit can be delivered

• A concise summary of analytics approaches and rationale by use case highlighted

• Clinical and commercial benefits clearly linked to addressing unmet needs in patients

• The panel raised several comments on other aspects of the application including:
  
  

  • Desire to see specific unmet needs within each use case description

  • Further explanation desirable around the potential benefits and impact of research on EDI and underrepresented populations

  • More direct linking of target outputs to patient benefit (e.g.patient/lay-focused channels)

  • Examples of third party companies (which provide data analytics support) desired